Ziad A. Massy

1.5k total citations
39 papers, 928 citations indexed

About

Ziad A. Massy is a scholar working on Nephrology, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Ziad A. Massy has authored 39 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nephrology, 9 papers in Nutrition and Dietetics and 7 papers in Surgery. Recurrent topics in Ziad A. Massy's work include Dialysis and Renal Disease Management (18 papers), Parathyroid Disorders and Treatments (9 papers) and Chronic Kidney Disease and Diabetes (5 papers). Ziad A. Massy is often cited by papers focused on Dialysis and Renal Disease Management (18 papers), Parathyroid Disorders and Treatments (9 papers) and Chronic Kidney Disease and Diabetes (5 papers). Ziad A. Massy collaborates with scholars based in France, United States and United Kingdom. Ziad A. Massy's co-authors include Thao Nguyen‐Khoa, Tilman B. Drüeke, Lucie Hénaut, Bernard Lacour, Sophie Liabeuf, Saı̈d Kamel, Aurélien Mary, Jean‐Marc Chillon, Claudine Saltiel and Christine Fumeron and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Ziad A. Massy

36 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziad A. Massy France 18 498 178 129 125 114 39 928
Aleksandar Sikole North Macedonia 18 504 1.0× 200 1.1× 177 1.4× 125 1.0× 118 1.0× 73 1.2k
Else van den Berg Netherlands 19 372 0.7× 182 1.0× 161 1.2× 128 1.0× 94 0.8× 43 1.1k
Shmuel Smetana Israel 11 519 1.0× 365 2.1× 131 1.0× 217 1.7× 182 1.6× 24 1.2k
C. Wanner Germany 17 639 1.3× 182 1.0× 167 1.3× 263 2.1× 160 1.4× 31 1.3k
Chi‐Feng Pan Taiwan 18 443 0.9× 69 0.4× 229 1.8× 125 1.0× 81 0.7× 33 891
Tomasz Stompór Poland 21 597 1.2× 104 0.6× 233 1.8× 228 1.8× 216 1.9× 106 1.3k
Shixiang Wang China 16 355 0.7× 94 0.5× 70 0.5× 85 0.7× 91 0.8× 60 801
B. Canaud France 5 384 0.8× 106 0.6× 102 0.8× 100 0.8× 75 0.7× 7 750
Aaron Knecht Israel 11 418 0.8× 319 1.8× 309 2.4× 214 1.7× 156 1.4× 24 1.2k
Giuliano Barsotti Italy 21 605 1.2× 111 0.6× 76 0.6× 170 1.4× 267 2.3× 45 1.1k

Countries citing papers authored by Ziad A. Massy

Since Specialization
Citations

This map shows the geographic impact of Ziad A. Massy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziad A. Massy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziad A. Massy more than expected).

Fields of papers citing papers by Ziad A. Massy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziad A. Massy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziad A. Massy. The network helps show where Ziad A. Massy may publish in the future.

Co-authorship network of co-authors of Ziad A. Massy

This figure shows the co-authorship network connecting the top 25 collaborators of Ziad A. Massy. A scholar is included among the top collaborators of Ziad A. Massy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziad A. Massy. Ziad A. Massy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capasso, Giovambattista, Casper Franssen, Alessandra Perna, et al.. (2025). Drivers and mechanisms of cognitive decline in chronic kidney disease. Nature Reviews Nephrology. 21(8). 536–552. 8 indexed citations
2.
Hénaut, Lucie, et al.. (2025). Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies. Clinical Kidney Journal. 18(Supplement_1). i27–i45.
3.
Laville, Solène M., Christian Jacquelinet, Christian Combe, et al.. (2024). Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study. Kidney Medicine. 6(12). 100912–100912.
4.
Bonnet, Fabrice, Beverley Balkau, Oriane Lambert, et al.. (2024). The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD‐REIN cohort study. Diabetes Obesity and Metabolism. 26(5). 1908–1918. 3 indexed citations
5.
Drüeke, Tilman B. & Ziad A. Massy. (2024). Calprotectin, a misnomer for another player in vascular calcification. Kidney International. 105(5). 915–918. 2 indexed citations
6.
Rossignol, Patrick, Faïez Zannad, Ziad A. Massy, et al.. (2023). ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST): Primary Results. Journal of the American Society of Nephrology. 34(11S). B2–B2. 1 indexed citations
7.
Meijers, Björn, Almudena Vega, Laurent Juillard, et al.. (2023). Extracorporeal Techniques in Kidney Failure. Blood Purification. 53(5). 343–357. 3 indexed citations
8.
Silbernagel, Günther, Kévin Duarte, Günter Fauler, et al.. (2022). High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study. European Journal of Preventive Cardiology. 29(13). 1731–1739. 2 indexed citations
9.
Wagner, Sandra, Thomas Merkling, Marie Metzger, et al.. (2022). Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort. Frontiers in Nutrition. 9. 772596–772596. 17 indexed citations
10.
Gonzalo‐Calvo, David de, Pablo Martínez‐Camblor, Christian Bär, et al.. (2020). Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids. Theranostics. 10(19). 8665–8676. 27 indexed citations
11.
Legrand, Karine, Élodie Speyer, Bénédicte Stengel, et al.. (2019). Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France. American Journal of Kidney Diseases. 75(6). 868–878. 76 indexed citations
12.
Massy, Ziad A. & Tilman B. Drüeke. (2015). Magnesium and cardiovascular complications of chronic kidney disease. Nature Reviews Nephrology. 11(7). 432–442. 54 indexed citations
13.
Oliveira, Rodrigo Cardoso de, Sophie Liabeuf, Hirokazu Okazaki, et al.. (2013). The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients. Clinical Kidney Journal. 6(1). 63–70. 15 indexed citations
14.
Chasseraud, Maud, et al.. (2011). Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand and Vascular Calcification. Therapeutic Apheresis and Dialysis. 15(2). 140–146. 18 indexed citations
15.
Weissinger, Eva M., Thao Nguyen‐Khoa, Christine Fumeron, et al.. (2005). Effects of oral vitamin C supplementation in hemodialysis patients: A proteomic assessment. PROTEOMICS. 6(3). 993–1000. 42 indexed citations
16.
Ivanovski, Ognen, Dorota Szumilak, Thao Nguyen‐Khoa, et al.. (2005). Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 180(2). 271–276. 34 indexed citations
17.
Fumeron, Christine, Thao Nguyen‐Khoa, Claudine Saltiel, et al.. (2005). Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrology Dialysis Transplantation. 20(9). 1874–1879. 79 indexed citations
18.
Massy, Ziad A., I. Ceballos, Thao Nguyen‐Khoa, et al.. (2001). Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney International. 59. S243–S245. 23 indexed citations
19.
Kitiyakara, Chagriya, J Gonin, Ziad A. Massy, & Christopher S. Wilcox. (2000). Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia. Current Opinion in Nephrology & Hypertension. 9(5). 477–487. 23 indexed citations
20.
Touam, Malik, J. Zingraff, Paul Jungers, et al.. (1999). Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney International. 56(6). 2292–2296. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandar Sikole Breakdown of academic impact, for papers by Else van den Berg Breakdown of academic impact, for papers by Shmuel Smetana Breakdown of academic impact, for papers by C. Wanner Breakdown of academic impact, for papers by Chi‐Feng Pan Breakdown of academic impact, for papers by Tomasz Stompór Breakdown of academic impact, for papers by Shixiang Wang Breakdown of academic impact, for papers by B. Canaud Breakdown of academic impact, for papers by Aaron Knecht Breakdown of academic impact, for papers by Giuliano Barsotti
Rankless by CCL
2026